2003年

  1. Kataoka K, Hasegawa K, Sawamura T, Fujita M, Yanazume T, Iwai-Kanai E, Kawamura T, Hirai T, Kita T, Nohara R: LOX-1 Pathway affects the extent of myocardial ischemia-reperfusion injury. Biochem. Biophys. Res. Commun. 300:656-660
  2. Ashida N, Takechi H, Kita T, Arai H: Vortex-mediated mechanical stress induces integrin-dependent cell adhesion mediated by inositol-1, 4, 5 triphosphate-sensitive Ca2+ release in THP-1 cells. J Biol Chem 278: 9327-9331
  3. Matsuzawa Y, Kita T, Mabuchi H, Matsuzaki M, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H, and the J-LIT Study Group: Sustained Reduction of Serum Cholesterol in Low-Dose 6-Year Simvastatin Treatment With Minimum Side Effects in 51, 321 Japanese Hypercholesterolemic Patients. -Implication of the J-LIT Study, a Large Scale Nationwide Cohort Study. Circ. J. 67: 287-294
  4. Nagai K, Arai H, Yanagita M, Matsubara T, Kanamori H, Nakano T, Iehara N, Fukatsu A, Kita T, Doi T: Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J. Biol. Chem. 278: 18229-34
  5. Tanaka M, Matsubayashi K, Yokode M, Kita T: Donepezil and athetosis in an elderly patient with Alzheimer's disease. J. Am. Geriatr. Soc. 51(6): 889-890
  6. Tabuchi A, Yoshioka A, Higashi T, Shirakawa R, Nishioka H, Kita T, Horiuchi H: Direct demonstration of involvement of protein kinase Calpha in the Ca2+-induced platelet aggregation. J.Biol.Chem. 18; 278(29): 26374-26379
  7. Watanabe T, Katsukura H, Shirai Y, Yamori M, Nishi T, Chiba T, Kita T, Wakatsuki Y: A liver tolerates a portal antigen by generating CD11c+ cells, which select Fas ligand+ Th2 cells via apoptosis. Hepatology. 38(2): 403-12
  8. Abe M, Hasegawa K, Wada H, Morimoto T, Yanazume T, Kawamura T, Hirai M, Furukawa Y, Kita T: GATA-6 is involved in PPARgamma-mediated activation of differentiated phenotype in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 23(3): 404-10
  9. Yanazume T, Hasegawa K, Morimoto T, Kawamura T, Wada H, Matsumori A, Kawase Y, Hirai M, Kita T: Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol Cell Biol. 23(10): 3593-606
  10. Iwai-Kanai E, Hasegawa K, Adachi S, Fujita M, Akao M, Kawamura T, Kita T: Effects of endothelin-1 on mitochondrial function during the protection against myocardial cell apoptosis. Biochem Biophys Res Commun.305(4): 898-903
  11. Watanabe T, Katsukura H, Shirai Y, Yamori M, Chiba T, Kita T, Wakatsuki Y: Helper CD4+ T cells for IgE response to a dietary antigen develop in the liver. J Allergy Clin Immunol. 111(6): 1375-85
  12. Shimaoka T, Nakayama T, Kume N, Takahashi S, Yamaguchi J, Minami M, Hayashida K, Kita T, Ohsumi J, Yoshie O, Yonehara S: Cutting edge: SR-PSOX/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain. J Immunol. 171(4): 1647-51
  13. Itoh T, Yoshida M, Chiba T, Kita T, Wakatsuki Y: A coordinated cytotoxic effect of IFN-gamma and cross-reactive antibodies in the pathogenesis of Helicobacter pylori gastritis. Helicobacter. 8(4): 268-78
  14. Yamada SI, Takechi H, Kanchiku I, Kita T, Kato N: Small conductance Ca2+ -dependent K+ channels are the target of spike-induced Ca2+ release in a feedback regulation of pyramidal cell excitability. J Neurophysiol.
  15. Shirakawa R, Higashi T, Tabuchi A, Yoshioka A, Nishioka H, Fukuda M, Kita T, Horiuchi H: Munc13-4 is a GTP-Rab27 binding protein regulating dense-core granule secretion in platelets. J Biol Chem
  16. Sato Y, Taniguchi R, Yamada T, Matsumori A: Measurements of serum cardiac troponin T in patients with heart failure. Am. Heart J. 145(4): 18-19.
  17. Nishio R, Shioi T, Sasayama S, Matsumori A: Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus. J. Am. Coll. Cardiol. 41(2): 340-345.
  18. Yanazume T, Hasegawa K, Morimoto T, Kawamura T, Wada H, Matsumori A, Kawase Y, Hirai M, Kita T: Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol. Cell Biol. 10: 3593-3606.
  19. Matsumori A: The 1st Candesartan Asian Advisors Meeting ― Highlight Report―Treatment of heart failure- A new efficacy parameter and future perspective. Medical Tribune Topic News Report.
  20. Kasuno K, Ono T, Matsumori A, Nogaki F, Kusano H, Watanabe H, Yodoi J, Muso E: Hepatitis C virus- associated tubulointerstitial injury. Am. J. Kidney Dis. 41(4): 767-775.
  21. Sato Y, Taniguchi R, Nagai K, Makiyama T, Okada H, Yamada T, Matsumori A: Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy. (letter) Heart 89: 659-660.
  22. Sasayama S, Ishii N, Ishikura F, Kamijima G, Ogawa S, Kanmatsuse K, Kimoto Y, Sakuma I, Nonogi H, Matsumori A, Yamamoto Y: Men's Health Study -Epidemiology of erectile dysfunction and cardiovascular disease- Circulation J. 67: 656-659.
  23. Kitaura-Inenaga K, Hara M, Higuchi H, Yamamoto K, Yamaki A, Ono K, Nakano A, Kinoshita M, Sasayama S, Matsumori A: Gene expression of cardiac mast cell chymase and tryptase in a murine model of heart failure caused by viral myocarditis. Circ J. 67: 881-884.
  24. Okazaki T, Tanaka Y, Nishio R, Mitsuiye T, Mizoguchi A, Wang J, Ishida M, Hiai H, Matsumori A, Minato N, Honjo T: Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat. Med. 9: 1477-1483.
  25. Yamamoto K, Shioi T, Uchiyama K, Miyamoto T, Sasayama S, Matsumori A: Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-kappa B activation in knockout mice. J. Am. Coll. Cardiol. 42: 2000-2006.
  26. Matsumori A: Efficacy and safety of oral candesartan cilexetil in patients with congestive heart failure. Eur. J. Heart Fail. 5: 669-677.
  27. Kakio T, Matsumori A, Ohashi N, Yamada T, Nobuhara M, Saito T, Kawamoto A, Taguchi A, Morita Y, Takahashi M, Sasayama S: The effect of hydrocortisone on reducing rates of restenosis and target lesion revascularization after coronary stenting less than 3 mm in stent diameter. Int. Med. 42(11): 1084-1089.
  28. Ito H, Nakano A, Kinoshita M, Matsumori A: Pioglitazone, a peroxisome proliferator- activaed receptor-g agonist, attenuates myocardial ischemia/reperfusion injury in a rat model. Lab. Invest. 83(12): 1715-1721.
  29. Matsumori A: 1. Introductory chapter, In "Cardiomyopathies and heart failure. Biomolecular, infections and immune mechanisms" (Ed. Matsumori A.), Kluwer Academic Publishers, Boston, U.S.A., pp1-15.
  30. Matsumori A, Ohashi N, Ito H, Furukawa Y, Hasegawa K, Sasayama S, Naruse T, Inoko H, and co-inovestigators: Genes of the major histocompability complex class II influence the phenotype of cardiomyopathies associated with hepatitis C virus infection, In "Cardiomyopathies and heart failure",(Ed, Matsumori A.), Kluwer Academic Publishers, Boston, U.S.A., pp515-521.
  31. Hara M, Ono K, Sasayama S, Matsumori A: The key role of mast cells in the evolution to congestive heart failure, In "Cardiomyopathies and heart failure", (Ed. Matsumori A.), Kluwer Academic Publishers, Boston, U.S.A., pp213-228.
  32. Njenga MK, Matsumori A, Gwathmey JK: Large animal model of viral myocarditis, In "Cardiomyopathies and heart failure", (Ed. Matsumori A.), Kluwer Academic Publishers, Boston, U.S.A., pp301-324.
  33. Sato Y, Yamada T, Matsumori A: Hepatitis C virus and cardiomyopathy, In "Cardiomyopathies and heart failure", (Ed. Matsumori A.), Kluwer Academic Publishers, Boston, U.S.A., pp325-339.
  34. Noguchi T, Kihara Y, Begin KJ, Gorga JA, Palmiter KA, LeWinter MM, VanBuren P: Altered myocardial thin-filament function in the failing Dahl salt-sensitive rat heart: amelioration by endothelin blockade. Circulation 107:630-635
  35. Izumi T, Kihara Y, Inagaki K, Iwanaga Y, Yoneda T, Onozawa Y, Sasayama S: Re-induction of T-type calcium channels by endothelin-1 in failing hearts in vivo and adult rat ventricular myocytes in vitro. Circulation 108:2530-2535
  36. Yoneda T, Kihara Y, Takenaka H, Onozawa Y, Sarai N, Kita T: RhoA Expression is not a Critical Determinant in Hypertension Evolution in Salt-Sensitive Dahl Rats. Med. Sci. Monit. 9:BR399-BR402
  37. Kume N, Kita T: New scavenger receptors and their functions in atherogenesis. Current Atherosclerosis Reports vol. 4: 253-257
  38. Kume N, Kita T: Roles of oxidized low-density lipoprotein and its receptors in the pathogenesis of atherosclerotic diseases. Geriatrics Gerontology International vol. 2: 172-178
  39. Shimaoka T, Nakayama T, Kume N, Takahashi S, Yamaguchi J, Minami M, Hayashida K, Kita T, Ohsumi J, Yoshie O, Yonehara S: SR-PSOX/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain. J. Immunol. vol. 171: 1647-1651
  40. Shimaoka T, Nakayama T, Fukumoto N, Kume N, Takahashi S, Yamaguchi J, Minami M, Hayashida K, Kita T, Ohsumi J, Yoshie O, Yonehara S: Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J. Leukoc. Biol. vol. 75: 267-274
  41. Yamauchi R, Tanaka M, Kume N, Minami M, Kawamoto T, Togi K, Shimaoka T, Takahashi S, Yamaguchi J, Nishina T, Kitaichi M, Komeda M, Manabe T, Yonehara S, Kita T: Upregulation of SR-PSOX/CXCL16 and recruitment of CD8+ T cells in cardiac valves during inflammatory valvular heart disease. Arterioscler. Thromb. Vasc. Biol. vol. 24: 282-287
  42. Kume N, Kita T : Apoptosis of vascular cells by oxidized LDL: involvement of caspases and LOX-1, and its implication in atherosclerotic plaque rupture. Circ. Res. vol. 94: 269-270
  43. Yui Y: Effect of trapidil on cardiovascular events in patients with coronary artery disease (results from the Japanese Multicenter Investigation for Cardiovascular Diseases-Mochida [JMIC-M]), Am. J. Cardiol.92: 789-793.
  44. Yui Y: Blood Pressure Lowering Treatment Trialist' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet 362: 1527-1535.
  45. Miwa K, Kishimoto C, Nakamura H, Makita T, Okuda N, Taniguchi A, Shioji K, Yodoi J, Sasayama S: Increased oxidative with elevated serum thioredoxin level patients with coronary spastic angina. Clin. Cardiol. 26:177-181.
  46. Miyamoto M, Kishimoto C, Shioji K, Lee DJ, Shimizu H, Ueda T, Yodoi J: Cutaneous arteriolar thioredoxin expression in patients with heart failure. Circ J. 67: 116-118.
  47. Kishimoto C, Shioji K, Kinoshita M, Iwase T, Tamaki S, Fujii M, Murashige A, Maruhashi H, Takeda S, Nonogi H, Hashimoto T: Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress. Int. J. Cardiol. 91: 173-178.
  48. Yuan Z, Kishimoto C, Sano H, Shioji K, Xu Y, Yokode M: Immunoglobulin treatment suppresses atherosclerosis in apolipoprotein E-deficient mice via the Fc portion.  Am. J. Physiol. 285: H899-H906.
  49. Yuan Z, Kishimoto C, Shioji K: Beneficial effects of low-dose benedipine in acute autoimmune myocarditis. Suppressive effects on inflammatory cytokines and inducible nitric oxide synthase. Circ. J. 67: 545-550.
  50. Yuan Z, Shioji K, Kishimoto C: Immunohistological analyses of myocardial infiltrating cells in various animal models of myocarditis. Exp & Clin. Cardiol. 8: 13-16.
  51. Kishimoto C, Tomioka N, Nakayama Y, Miyamoto M: Anti-oxidant effects of coenzyme Q10 on experimental viral myocarditis in mice. J. Cardiovasc. Pharmacol. 42:588-592. Kishimoto C, Hiraoka Y, Takamatsu N, Takada H, Kamiya H, Ochiai H: An in vivo model of autoimmune post-coxsackievirus B3 myocarditis in severe combined immunodeficiency (SCID) mouse. Cardiovasc. Res. 60:397-403.
  52. Yuan Z, Liu Y, Zhang J, Kishimoto C, Wang Y, Ma A, Liu Z: Peroxisome proliferation-activated receptor-γ ligands ameliorate experimental autoimmune myocarditis. Cardiovasc. Res. 59:685-694.
  53. Nimata M, Kishimoto C, Shioji K, Ishizaki K, Kitaguchi S, Hashimoto T, Nagata N, Kawai C: Expression of thioredoxin in the endomyocardial biopsy samples in patients with cardiomyopathies. Mol. Cell. Biochem. 248:193-196.
  54. Yuan Z, Kishimoto C, Shioji K, Nakamura H, Yodoi J, Sasayama S: Temocapril treatment ameliorates autoimmune myocarditis associated with enhanced cardiomyocyte thioredoxin expression. Mol. Cell. Biochem. 248:185-192.
  55. Makino T, Ono T, Matsuyama K, Nogaki F, Miyawaki S, Honda G, Muso E: Suppressive effects of Perilla frutescens on IgA nephropathy in HIGA mice. Nephrol. Dial. Transplant. 18: 484-490.
  56. Kasuno K, Ono T, Matsumori A, Nogaki F, Kusano H, Watanabe H, Yodoi J, Muso E: Hepatitis C virus-associated tubulointerstitial injury. Am. J. Kidney. Dis. 41(4) 767-775.
  57. Hamada K, Nagai S, Ono T, Muso E, Nagao T, Shigematsu M, Izumi T, Mishima M: Sarcoidosis complicated with IgA nephropathy. Sarcoidosis Vasc. Diffuse. Lung Dis. 20: 69-73.
  58. Handa T, Ono T, Watanabe H, Takeda T, Muso E, Kita T: Glomerulonephritis induced by Methicillin-sensitive Staphylococcus aureus infection. Clin. Exp. Nephrol. 7: 247-249.
  59. Kasuno K, Nakamura H, Ono T, Muso E, Yodoi J: Protective roles of thioredoxin, a redox-regulating protein, in renal ischemia-reperfusion injury. Kidney Int. 64: 1273-1282.
  60. Kataoka K, Hasegawa K, Sawamura T, Fujita M, Yanazume T, Iwai-Kanai E, Kawamura T, Hirai T, Kita T, Nohara R: LOX-1 pathway affects the extent of myocardial ischemia-reperfusion injury. Biochem. Biophys. Res Commun. 300: 656-660.
  61. Abe M, Hasegawa K, Wada H, Morimoto T, Yanazume T, Kawamura T, Hirai M, Furukawa Y, Kita T: GATA-6 is involved in PPAR?-mediated activation of differentiated phenotyoe in human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol.23: 404-410.
  62. Yanazume T, Hasegawa K, Morimoto T, Kawamura T, Wada H, Matsumori A, Kawase Y, Hirai M, Kita T: Cardiac p300 is involved in myocyte growth with decompensated heart failure. Mol. Cell. Biol.23: 3593-3606.
  63. Iwai-Kanai E, Hasegawa K, Adachi S, Fujita M, Akao M, Kawamura T, Kita T: Effects of endothelin-1 on mitochondrial function during the protection against myocardial cell apoptosis. Biochem. Biophys. Res. Commun.305: 898-903.
  64. Yanazume T, Morimoto T, Wada H, Kawamura T, Hasegawa K: Biological role of p300 in cardiac myocytes. Mol. Cell. Biochem.248: 115-119.
  65. Sato Y, Taniguchi R, Yamada T, Matsumori A: Measurements of serum cardiac troponin T in patients with heart failure. Am. Heart J.: 145: e18
  66. Sato Y, Taniguchi R, Nagai K, Makiyama T, Okada H, Yamada T, Matsumori A, Takatsu Y: Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy. Heart 89:659-60.
  67. Goishi K, Lee P, Davidson AJ, Nishi E, Zon LI and Klagsbrun M: Inhibition of zebrafish epidermal growth factor receptor activity results in cardiovascular defects. Mech Dev. 120: 811-822.
  68. Nishi E, Higashiyama S and Klagsbrun M: Heparin-binding epidermal growth factor-like growth factor. In Encyclopedia of Hormones. Ed.by Henry HL and Norman AW Academic Press, San Diego, 2: 235-241
  69. Ikemoto M, Tanaka T, Takai Y, Murayama H, Tanaka K, Fujita M: New ELISA system for myeloid-related protein complex (MRP 8/14) and its clinical significance as a sensitive marker for inflammatory responses associated with transplant rejection. Clin. Chem. 49(4): 594-600.
  70. Iwakura A, Fujita M, Kataoka K, Tambara K, Sakakibara Y, Komeda M, Tabata Y: Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model. Heart and Vessels 18:93-99.
  71. Fujita M, Mizuno K, Ho M, Tsukahara R, Miyamoto A, Miki O, Ishii K, Miwa K: Sarpogrelate treatment reduces restenosis after coronary stenting. Am. Heart J. 145(3): e16.
  72. Iwakura A, Tabata Y, Koyama T, Doi K, Nishimura K, Kataoka K, Fujita M, Komeda M: Gelatin sheet incorporating basic fibroblast growth factor enhances sternal healing after harvesting bilateral internal thoracic arteries. J. Thorac. Cardiovasc. Surg. 126(4): 1113-1120.
  73. Fujita M: Angiogenic therapy by coronary collateral recruitment and arteriogenesis. In Myocardial Ischemia and Preconditioning, ed. by Dhalla NS, Takeda N, Singh M, Lukas A. Kluwer Academic Publishers, Boston, 13-22.

ページの先頭へ